Learn about the increased pressure in the portal vein, its causes like cirrhosis, and resulting complications such as ...

Treatment for portal hypertension in patients with cirrhosis is based on the use of β-blockers with or without organic nitrates; however, these agents are effective in less than 50% of patients ...

Iconic actor and filmmaker Manoj Kumar passed away at the age of 87, battling heart conditions and decompensated liver ...

Medically reviewed by Jay N. Yepuri, MD Metabolic dysfunction-associated fatty liver disease (MAFLD) occurs when excess fat builds up in the liver. MAFLD can progress to metabolic ...

Portal hypertension may not be associated with any clinical abnormalities but is usually accompanied by splenomegaly, esophageal varices, ascites or symptoms resulting from shunting of venous ...

Thus, screening all patients with cirrhosis with this technique to ... and grading of esophageal varices in patients with portal hypertension. The results of the pilot studies varied.

Purpose Published evidence on the incidence and predictors of venous thromboembolism (VTE) in patients with cirrhosis of the liver is reviewed. Summary The frequently observed phenomenon of ...

and in groups of patients with nonalcoholic cirrhosis, whereas it was ineffective in patients with class B or C portal hypertension. [15] Another two interesting studies are reported in the review ...

NORCROSS, Ga., March 31, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...

Veteran actor Manoj Kumar passes away at 87 due to cardiogenic shock. Understand the causes and symptoms of this severe heart ...

Joel Lewis, Chief Executive Officer and President of Galectin Therapeutics (GALT), said “In the U.S. approximately 5 million adults are ...